首页|醋酸曲普瑞林联合小剂量替勃龙用于卵巢子宫内膜异位症术后43例的回顾性研究

醋酸曲普瑞林联合小剂量替勃龙用于卵巢子宫内膜异位症术后43例的回顾性研究

扫码查看
目的 探讨醋酸曲普瑞林联合小剂量替勃龙治疗卵巢子宫内膜异位症的有效性。方法 以信阳职业技术学院附属医院 2020 年 1 月至 2021 年 12 月收治的卵巢子宫内膜异位症患者 86 例为研究对象,根据治疗方式不同分为两组,每组各 43 例。两组均行腹腔镜手术治疗,对照组皮下注射醋酸曲普瑞林,观察组在此基础上口服小剂量替勃龙。比较两组临床疗效,骨密度(腰椎及股骨粗隆骨骨密度),性激素水平[黄体生成素(LH)、卵泡刺激素(FSH)、雌二醇(E2)],血管内皮功能相关指标[血管内皮生长因子(VEGF)、基质金属蛋白酶-2(MMP-2)、MMP-9、多配体蛋白多糖-1(Syndecan-1)],不良反应。结果 观察组总有效率 95。35%高于对照组 81。40%(P<0。05);观察组术后 6个月、术后 12 个月腰椎骨密度高于对照组(P<0。05);术后 6 个月、术后 12 个月,两组股骨粗隆骨密度比较,差异无统计学意义(P>0。05);观察组术后 6 个月血清E2、FSH水平高于对照组,LH水平低于对照组(P<0。05);观察组术后 6 个月血清VEGF、MMP-2、MMP-9、Syndecan-1 水平均明显低于对照组(P<0。05);治疗期间,观察组不良反应发生率 6。98%与对照组 11。63%相比,差异无统计学意义(P<0。05)。结论 醋酸曲普瑞林联合小剂量替勃龙能有效地减少子宫内膜异位症患者术后的骨密度流失,调节性激素水平,改善血管内皮功能,效果确切,安全可靠。
Application and Retrospective Study of Triptorelin Acetate Combined with Low-dose Tibolone in 43 Cases of Patients with Ovarian Endometriosis after Surgery
Objective To investigate the effectiveness of triptorelin acetate in combination with low-dose tibolone in the treatment of ovarian endometriosis(EMS).Methods 86 patients with ovarian endometriosis admitted to The Affiliated Hospital of Xinyang Vocational and Technical College from January 2020 to December 2021 were selected as the research subjects.They were divided into different treatment groups,with 43 patients in each group.Two groups were treated with laparoscopic surgery,and the control group was treated with subcutaneous injection of triptorelin acetate,and the observation group was treated with oral tibolone on this basis.The clinical efficacy,bone density(bone density of the lumbar spine and femoral trochanter),sex hormone levels[luteinizing hormone(LH),follicle-stimulating hormone(FSH),estradiol(E2)],indicators related to vascular endothelial function[vascular endothelial growth factor(VEGF),matrix metalloproteinase-2(MMP-2),MMP-9,multiligand proteoglycan-1(Syndecan-1)],and adverse effects were compared between the two groups.Results The total effective rate of the observation group was 95.35%higher than that of the control group 81.40%(P<0.05);the lumbar bone density at 6 months and 12 months after surgery was higher in the observation group than in the control group(P<0.05);there was no statistically significant difference in the bone density of the femoral trochanter between the 2 groups at 6 months and 12 months after surgery(P>0.05).Serum E2 and FSH levels were higher and LH levels were lower in the observation group than in the control group 6 months after surgery(P<0.05);serum VEGF,MMP-2,MMP-9,and Syndecan-1 levels were significantly lower in the combined group than in the control group 6 months after surgery(P<0.05);during the treatment period,the incidence of adverse reactions was 6.98%in the observation group compared with 11.63%in the control group,the difference was not statistically significant(P<0.05).Conclusion Triptorelin acetate combined with low-dose tibolone can effectively reduce postoperative bone density loss,regulate sex hormone levels and improve vascular endothelial function in EMS patients with definite,safe and reliable effects.

EndometriosisTriptorelin acetateTiboloneSex hormone

孙挺

展开 >

信阳职业技术学院附属医院,河南 信阳 464000

子宫内膜异位症 醋酸曲普瑞林 替勃龙 性激素

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(2)
  • 16